Author

Katie Y. Zhu

Observed names: K Zhu, Kai Zhu, Katie Yuan Zhu

Institution: University of British Columbia

Observed institutions: BC Cancer Agency, University of British Columbia

ORCID: 0000-0002-9994-3409

Observed ORCID: 0000-0002-9994-3409

OpenAlex ID: A5069413862

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients

2020 · Lasse H. Jakobsen, Fredrik Ellin, et al. · British Journal of Haematology · 24

Excellent real‐world outcomes of adults with Burkitt lymphoma treated with CODOX ‐M/ IVAC plus or minus rituximab

2018 · Katie Y. Zhu, Kevin W. Song, et al. · British Journal of Haematology · 24

Assessing appropriateness of pediatric emergency department visits: is it even possible?

2020 · Jessica E. Paul, Katie Y. Zhu, et al. · Canadian Journal of Emergency Medicine · 6

A95 Incidence of Luminal Gastrointestinal Cancers in Patients With Cirrhosis: a Systematic Review and Meta-analysis

2024 · Manisha Jogendran, Kai Zhu, et al. · Journal of the Canadian Association of Gastroenterology

A251 Non-alcoholic Fatty Liver Disease at a Canadian Tertiary Care Centre: Risk Factors and Severity of Disease

2023 · N K Klemm, K Zhu, et al. · Journal of the Canadian Association of Gastroenterology

A98 Fecal Leukocyte Esterase: an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease

2022 · N K Klemm, R Trasolini, et al. · Journal of the Canadian Association of Gastroenterology

Inferior Outcomes for Older Patients in the Adolescent and Young Adult (AYA) Population with Burkitt Lymphoma Treated with Intensive Immunochemotherapy: An International Study of 108 Patients

2019 · Fredrik Ellin, Knut B. Smeland, et al. · Blood

Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada

2016 · Katie Y. Zhu, Kevin W. Song, et al. · Blood

Works count: 8

Citation count: 54

H-index: 3

I10-index: 2